DE69528817D1 - Peptide und dessen verwendungen gegen psoriasis - Google Patents

Peptide und dessen verwendungen gegen psoriasis

Info

Publication number
DE69528817D1
DE69528817D1 DE69528817T DE69528817T DE69528817D1 DE 69528817 D1 DE69528817 D1 DE 69528817D1 DE 69528817 T DE69528817 T DE 69528817T DE 69528817 T DE69528817 T DE 69528817T DE 69528817 D1 DE69528817 D1 DE 69528817D1
Authority
DE
Germany
Prior art keywords
psoriasis
peptide
fragment
methods
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528817T
Other languages
English (en)
Other versions
DE69528817T2 (de
Inventor
C Chang
W Brostoff
J Carlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immune Response Corp
Original Assignee
Immune Response Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp filed Critical Immune Response Corp
Application granted granted Critical
Publication of DE69528817D1 publication Critical patent/DE69528817D1/de
Publication of DE69528817T2 publication Critical patent/DE69528817T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
DE69528817T 1994-01-14 1995-01-13 Peptide und dessen verwendungen gegen psoriasis Expired - Fee Related DE69528817T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/182,967 US6413516B1 (en) 1989-03-21 1994-01-14 Peptides and methods against psoriasis
PCT/US1995/000658 WO1995019375A1 (en) 1994-01-14 1995-01-13 Peptides and methods against psoriasis

Publications (2)

Publication Number Publication Date
DE69528817D1 true DE69528817D1 (de) 2002-12-19
DE69528817T2 DE69528817T2 (de) 2003-09-11

Family

ID=22670842

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528817T Expired - Fee Related DE69528817T2 (de) 1994-01-14 1995-01-13 Peptide und dessen verwendungen gegen psoriasis

Country Status (14)

Country Link
US (1) US6413516B1 (de)
EP (1) EP0738281B1 (de)
JP (2) JPH09508112A (de)
CN (1) CN1138865A (de)
AT (1) ATE227738T1 (de)
BR (1) BR9506511A (de)
CA (1) CA2179280A1 (de)
DE (1) DE69528817T2 (de)
ES (1) ES2184791T3 (de)
FI (1) FI962836A0 (de)
MX (1) MX9602473A (de)
NO (1) NO962943L (de)
NZ (1) NZ279987A (de)
WO (1) WO1995019375A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0716992D0 (en) * 2007-08-31 2007-10-10 Immune Targeting Systems Its L Influenza antigen delivery vectors and constructs
GB0408164D0 (en) * 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
JP2009266963A (ja) * 2008-04-23 2009-11-12 Sumitomo Electric Ind Ltd 窒化物系発光素子、及び半導体発光素子を製造する方法
KR20230084508A (ko) * 2020-09-11 2023-06-13 얀센 바이오테크 인코포레이티드 베타 사슬 매개 면역을 조절하기 위한 방법 및 조성물
EP4277645A1 (de) 2021-12-16 2023-11-22 Ramakrishna Reddy Isanaka Stabile antiangiogene und entzündungshemmende pharmazeutische formulierung und pharmazeutische kombination zur behandlung und prävention von psoriasis
CN116466095B (zh) * 2023-06-15 2023-09-01 朗肽生物制药股份有限公司 一种多肽及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174366B1 (de) * 1984-03-01 1994-10-26 The Board Of Trustees Of The Leland Stanford Junior University T-zellenrezeptor, spezifisch für antigenpolypeptide und verwandte polynukleotide
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
IL95125A (en) * 1989-07-19 1995-07-31 Vandenbark Arthur Allen T cell peptides receive a method for their selection and preparation, and pharmaceutical preparations containing them
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
WO1993006135A1 (en) 1991-09-23 1993-04-01 Genentech, Inc. Diagnosing and treating autoimmune disorders
CA2126686A1 (en) * 1991-12-24 1993-07-08 Mark D. Howell Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations

Also Published As

Publication number Publication date
ES2184791T3 (es) 2003-04-16
AU1728295A (en) 1995-08-01
CN1138865A (zh) 1996-12-25
NO962943L (no) 1996-09-13
WO1995019375A1 (en) 1995-07-20
JPH09508112A (ja) 1997-08-19
MX9602473A (es) 1997-05-31
DE69528817T2 (de) 2003-09-11
CA2179280A1 (en) 1995-07-20
ATE227738T1 (de) 2002-11-15
FI962836A (fi) 1996-07-12
EP0738281A1 (de) 1996-10-23
FI962836A0 (fi) 1996-07-12
US6413516B1 (en) 2002-07-02
AU697910B2 (en) 1998-10-22
NO962943D0 (no) 1996-07-12
BR9506511A (pt) 1997-09-09
EP0738281B1 (de) 2002-11-13
NZ279987A (en) 1999-09-29
JP2001288108A (ja) 2001-10-16

Similar Documents

Publication Publication Date Title
Maggi The mammalian tachykinin receptors
MX9603002A (es) Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos.
DK0669979T3 (da) C-C CKR-1, kemokinreceptor
WO1999000410A3 (en) Human extracellular matrix proteins
DK0751992T3 (da) Karendotelvækstfaktor 2
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
AR004860A1 (es) Anticuerpos mono o policionales, anticuerpos conjugados, o sus fragmentos, su utilizacion y metodo de diagnostico in vitro de patologias correlacionadas con una expresion anormal del receptor de la il-13, a partir de muestras biologicas susceptibles de contener el receptor de la il-13 expresado a un nivel anormal
NO20074516L (no) Pattedyrcytokinlignende polypeptid-1
EP0871486A4 (de) Epitope von diphtheriatoxin
ES2150949T3 (es) Regulacion de la actividad de linfocitos con la ayuda de peptidos hla.
DE69635455D1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
DE69840509D1 (de) Apoptose-bezogene verbindungen und deren verwendung
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
DE69528817D1 (de) Peptide und dessen verwendungen gegen psoriasis
DE69534419D1 (de) Intrazelluläre isoform von interleukin-1 rezeptor antagonist
NO952385D0 (no) Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen
ATE169680T1 (de) 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper
NO963366L (no) Peptider og fremgangsmåte for behandling av diabetes
DE69825629D1 (de) Säugertier edg-7 rezeptor homologen
CY1108126T1 (el) Μεθοδοι ελεγχου διαφοροποιησης και αναπτυξης κυτταρου χρησιμοποιωντας πρωτεϊνη συντηξης και ενα φαρμακο
WO1999021994A3 (en) Human vesicle membrane protein-like proteins
EA199800959A1 (ru) ПРИМЕНЕНИЕ ГЕНЕТИЧЕСКОЙ МОДИФИКАЦИИ В ГЕНЕ b3- СУБЪЕДИНИЦЫ ЧЕЛОВЕЧЕСКОГО G-ПРОТЕИНА ДЛЯ ДИАГНОСТИКИ ЗАБОЛЕВАНИЙ
DK0946591T3 (da) Klonede glucagon-lignende peptid-2 receptorer
EP0763597A3 (de) Verwendung von Cytohesin-PH-Peptiden zur Beeinflussung der Adhäsionsfähigkeit von Integrinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee